Maternal serum preptin levels in the pathogenesis and diagnosis of gestational diabetes mellitus
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessTarih
2023Yazar
Kıraç Utku, İremDemir, Esra
Özkan, Hanişe
Sahtiyancı, Berrak
Uzun, Hafize
Ekinci, İskender
Büyükkaba, Mitat
Durmuş, Sinem
Akarsu, Murat
Gelisgen, Remise
Tabak, Ömür
Üst veri
Tüm öğe kaydını gösterKünye
Kıraç Utku, İ., Demir, E., Özkan, H., Sahtiyancı, B., Uzun, H., Ekinci, İ. ... Tabak, Ö. (2023). Maternal serum preptin levels in the pathogenesis and diagnosis of gestational diabetes mellitus. Journal of Medical Biochemistry, 42(2), 311-317. https://dx.doi.org/10.5937/jomb0-36287Özet
Background: Gestational diabetes mellitus (GDM) is a
metabolic disorder that occurs during pregnancy that
increases both maternal and fetal mortality and morbidity.
It was investigated whether there is a change in circulating
levels of preptin, a new peptide secreted from pancreatic
beta cells, due to GDM in pregnant women. The relationship between serum preptin levels with insulin and other
metabolic parameters was also evaluated in these subjects.
Methods: Eighty-five patients diagnosed as GDM and 89
healthy pregnant women with 75 mg oral glucose tolerance test (OGTT) was assessed in terms of serum preptin
levels.
Results: The serum preptin levels of the GDM group were
significantly higher than those of the control group
(p=0.001; p < 0.01). For the cut-off value of preptin
measurement of 335.3 ng/L, the sensitivity was 97.65%,
specificity was 87.64%, positive predictive value was 88.3%
and negative predictive value was 97.5%. The risk of developing the disease is 294.273 times higher in patients with
preptin level of 335.3 and above. Conclusions: We think that the reason for the increase in
serum preptin levels in GDM is probably the response to
glucose. The current results indicate that preptin plays an
important role in elucidating the pathology of GDM. In
addition, the search for a practical marker for the diagnosis
of GDM suggests that the measurement of preptin level is
promising. Uvod: Gestacijski dijabetes melitus (GDM) je metaboli~ki
poreme}aj koji se javlja tokom trudno}e i pove}ava smrtnost i morbiditet i majke i fetusa. Ispitivano je da li po stoji
promena u cirkuli{u}im nivoima preptina, novog peptida
izlu~enog iz beta }elija pankreasa, usled GDM kod trudnica. Odnos izme|u nivoa preptina u serumu sa insulinom i
drugih metaboli~kih parametara je tako|e procenjen kod
ovih ispitanika.
Metode: Osamdeset pet pacijenata sa dijagnozom GDM i
89 zdravih trudnica sa 75 mg oralnim testom tolerancije
glukoze (OGTT) je procenjeno u smislu nivoa preptina u
serumu.
Rezultati: Nivoi preptina u serumu GDM grupe bili su
zna~ajno vi{i od onih u kontrolnoj grupi (p=0,001; p <
0,01). Za grani~nu vrednost merenja preptina od 335,3
ng/L, osetljivost je bila 97,65%, specifi~nost je bila
87,64%, pozitivna prediktivna vrednost je bila 88,3% i ne -
gativna prediktivna vrednost je bila 97,5%. Rizik od razvoja
bolesti je 294.273 puta ve}i kod pacijenata sa nivoom
preptina od 335,3 i vi{e. Zaklju~ak: Smatramo da je razlog za pove}anje nivoa
serumskog preptina u GDM verovatno odgovor na glukozu.
Sada{nji rezultati pokazuju da preptin igra va`nu ulogu u
rasvetljavanju patologije GDM. Pored toga, potraga za
prakti~nim markerom za dijagnozu GDM-a sugeri{e da je
merenje nivoa preptina obe}avaju}e.
WoS Q Kategorisi
Q4Scopus Q Kategorisi
Q3Kaynak
Journal of Medical BiochemistryCilt
42Sayı
2Koleksiyonlar
- Makale Koleksiyonu [3801]
- PubMed İndeksli Yayınlar Koleksiyonu [4264]
- Scopus İndeksli Yayınlar Koleksiyonu [6620]
- WoS İndeksli Yayınlar Koleksiyonu [6696]